13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q3 2016. See the latest, Q2 2026 →
Reported value
$23.18B
−1.5% on the quarter before
Positions
62
23 new · 16 sold out
Top 10
53.3%
of the value
Est. gain
+$1.67B
on stocks held all quarter
Est. return
+9.9%
on those stocks since Q2 2016
Positions as of Sep 30, 2016, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2016. Striped tiles are options.
Largest buys
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$462.7MAdded · 1.2% → 3.4%+8,033,492 shares
- Canadian Pac Ry Ltd~$404.1MAdded · 0.5% → 2.4%+2,646,250 shares
- Bank Amer Corp~$393.0MNew · 0.0% → 1.7%+25,110,973 shares
- Constellation Brands Inc~$368.0MAdded · 0.3% → 1.9%+2,210,077 shares
- Lyondellbasell Industries N~$319.4MNew · 0.0% → 1.4%+3,960,078 shares
- Universal Hlth Svcs Inc~$237.7MNew · 0.0% → 1.0%+1,929,192 shares
- Salesforce~$214.9MNew · 0.0% → 0.9%+3,013,051 shares
- Lowes Cos Inc~$195.5MNew · 0.0% → 0.8%+2,707,580 shares
- Johnson Ctls Intl Plc~$184.1MNew · 0.0% → 0.8%+3,957,199 shares
- Alphabet~$178.7MAdded · 2.5% → 3.6%+229,962 shares
Largest sells
Since Q2 2016, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Broadcom Ltd~$977.1MCut · 6.7% → 3.4%−5,663,754 shares
- Newell Brands Inc~$482.6MSold out · 2.1% → 0.0%−9,936,480 shares
- Allergan Plc~$448.2MSold out · 1.9% → 0.0%−1,939,703 shares
- Teva Pharmaceutical Inds Ltd~$370.5MCut · 5.9% → 3.9%−8,052,436 shares
- Netflix~$360.0MCut · 2.4% → 1.1%−3,653,304 shares
- Davita Healthcare Partners I~$356.6MSold out · 1.5% → 0.0%−4,611,729 shares
- Alibaba~$324.1MCut · 1.4% → 0.4%−3,063,900 shares
- Biogen Inc~$320.6MCut · 3.3% → 3.0%−1,024,171 shares
- Air Prods & Chems Inc~$319.0MCut · 4.2% → 3.1%−2,122,048 shares
- Amazon~$292.8MCut · 10.0% → 10.6%−349,679 shares
Holdings
As of Sep 30, 2016. Changes are in shares against Jun 30, 2016, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AmazonCOM · shares −11% · price +17.0% | 10.6% | $2.45B | +$356.5M | ||||||||
| MetaCL A · shares −6.9% · price +12.2% | 10.4% | $2.40B | +$262.3M | ||||||||
| AlphabetCAP STK CL A · shares +9.4% · price +14.3% | 6.8% | $1.58B | +$180.4M | ||||||||
| Cabot Oil & Gas CorpCOM · shares +1.9% · price +0.2% | 4.0% | $928.8M | +$2.1M | ||||||||
| Encana CorpCOM · shares +7.7% · price +34.4% | 3.9% | $909.1M | +$216.0M | ||||||||
| Teva Pharmaceutical Inds LtdADR · shares −29% · price −8.4% | 3.9% | $905.7M | −$83.1M | ||||||||
| AlphabetCAP STK CL C · shares +27% · price +12.3% | 3.6% | $832.6M | +$71.7M | ||||||||
| MicrosoftCOM · shares +143% · price +12.6% | 3.4% | $787.2M | +$36.2M | ||||||||
| Broadcom LtdSHS · shares −55% · price +11.0% | 3.4% | $786.0M | +$78.0M | ||||||||
| MastercardCL A · shares +19% · price +15.6% | 3.4% | $782.0M | +$88.2M | ||||||||
| Air Prods & Chems IncCOM · shares −31% · price +5.8% | 3.1% | $725.0M | +$40.0M | ||||||||
| Jd Com IncSPON ADR CL A · shares +21% · price +22.9% | 3.1% | $711.1M | +$109.3M | ||||||||
| Biogen IncCOM · shares −32% · price +29.4% | 3.0% | $684.4M | +$155.7M | ||||||||
| T Mobile Us IncCOM · shares −1.5% · price +8.0% | 2.8% | $642.7M | +$47.5M | ||||||||
| Southwestern Energy CoCOM · shares +12% · price +10.0% | 2.5% | $584.9M | +$47.5M | ||||||||
| Canadian Pac Ry LtdCOM · shares +279% · price +18.6% | 2.4% | $548.9M | +$22.7M | ||||||||
| Anadarko Pete CorpCOM · shares +9.4% · price +19.0% | 2.3% | $541.0M | +$78.9M | ||||||||
| Eli LillyCOM · shares −35% · price +1.9% | 2.1% | $489.0M | +$9.2M | ||||||||
| Constellation Brands IncCL A · shares +475% · price +0.7% | 1.9% | $445.4M | +$507,311 | ||||||||
| Bank Amer CorpCOM · shares New | 1.7% | $393.0M | — | ||||||||
| Rice Energy IncCOM · shares +19% · price +18.5% | 1.7% | $390.9M | +$51.3M | ||||||||
| Range Res CorpCOM · shares +5.4% · price −10.2% | 1.6% | $381.1M | −$41.0M | ||||||||
| Lyondellbasell Industries NSHS - A - · shares New | 1.4% | $319.4M | — | ||||||||
| Gulfport Energy CorpCOM NEW · shares +20% · price −9.6% | 1.3% | $304.9M | −$27.0M | ||||||||
| Calpine CorpCOM NEW · shares +4.0% · price −14.3% | 1.2% | $267.8M | −$43.0M | ||||||||
| Total · 62 positions | 100% | $23.18B | +$1.67B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2016 to Q3 2016: 39 stocks held throughout, up $1.67B (+9.9%).
- Amazon+$356.5M+17%
- Meta+$262.3M+12%
- Encana Corp+$216.0M+34%
- Alphabet+$180.4M+14%
- Biogen Inc+$155.7M+29%
- Gulfport Energy Corp−$27.0M−10%
- Range Res Corp−$41.0M−10%
- Calpine Corp−$43.0M−14%
- Dynegy Inc New Del−$44.3M−28%
- Teva Pharmaceutical Inds Ltd−$83.1M−8%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |